InsidersTradesSigma
Genovis A/B Stock: price and directors' dealings · Finland · FIN-FSA
Follow the Genovis A/B stock price and the full management transaction log of the company, a publicly traded company based in Finland. Shares are listed on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, Genovis A/B has recorded 1 insider filings. Market capitalisation: €1.3bn. The latest transaction was reported on 27 May 2025 (Purchase). Among the most active insiders: torben jörgensen. The full history is free.
1
Insider Decl.
0
Thresholds
€94,471
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Genovis A/B Strong Buy (bullish), based on 3 analysts. Average price target: SEK 32.67.
21Σ signal
Fundamental score
Ranked 12,066 of 26,132 companies
54.0
score / 100
Value35
Quality74
FCF yld1.6%
Earn yld1.9%
EV/EBITDA30.3x
ROE9.5%
Gross mgn90%
Net mgn18%
Debt/EBITDA1.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 27 May 2025
Declarations1 total
38,340 shares@ €2.4640.0072% mcap100.0% of flowAktieFI:A003O980-1
Ideal exit: 20 Feb 2026 (T+270)
1 of 1 declaration